The treatment of Peyronie's disease with tamoxifen

Br J Urol. 1992 Dec;70(6):648-51. doi: 10.1111/j.1464-410x.1992.tb15836.x.

Abstract

This is a preliminary study of the treatment of 36 patients with Peyronie's disease who received tamoxifen 20 mg twice daily for 3 months. An improvement occurred in 16 of 20 patients with penile pain, in 11 of 31 patients with an erectile deformity and 12 of 35 patients had a plaque shrinkage of at least 1 cm. Some improvement occurred in 6 of the 8 patients with a histologically confirmed inflammatory infiltrate of the plaque but not in any of the 4 patients without an infiltrate. The inflammatory infiltrate was found in patients in whom the duration of the disease was less than 4 months.

MeSH terms

  • Adult
  • Aged
  • Humans
  • Male
  • Middle Aged
  • Penile Induration / drug therapy*
  • Penile Induration / pathology
  • Penis / pathology
  • Tamoxifen / therapeutic use*
  • Time Factors

Substances

  • Tamoxifen